Cited 144 time in
Collaborative Power of Nrf2 and PPAR gamma Activators against Metabolic and Drug-Induced Oxidative Injury
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Lee, Choongho | - |
| dc.date.accessioned | 2024-08-08T01:01:55Z | - |
| dc.date.available | 2024-08-08T01:01:55Z | - |
| dc.date.issued | 2017 | - |
| dc.identifier.issn | 1942-0900 | - |
| dc.identifier.issn | 1942-0994 | - |
| dc.identifier.uri | https://scholarworks.dongguk.edu/handle/sw.dongguk/14802 | - |
| dc.description.abstract | Mammalian cells have evolved a unique strategy to protect themselves against oxidative damage induced by reactive oxygen species (ROS). Especially, two transcription factors, nuclear factor erythroid 2p45-related factor 2 (Nrf2) and peroxisome proliferatoractivated receptor gamma (PPAR gamma), have been shown to play key roles in establishing this cellular antioxidative defense system. Recently, several researchers reported ameliorating effects of pharmacological activators for these Nrf2 and PPAR gamma pathways on the progression of various metabolic disorders and drug-induced organ injuries by oxidative stress. In this review, general features of Nrf2 and PPAR gamma pathways in the context of oxidative protection will be summarized first. Then, a number of successful applications of natural and synthetic Nrf2 and PPAR gamma activators to the alleviation of pathological and drug-related oxidative damage will be discussed later. | - |
| dc.format.extent | 14 | - |
| dc.language | 영어 | - |
| dc.language.iso | ENG | - |
| dc.publisher | HINDAWI LTD | - |
| dc.title | Collaborative Power of Nrf2 and PPAR gamma Activators against Metabolic and Drug-Induced Oxidative Injury | - |
| dc.type | Article | - |
| dc.publisher.location | 영국 | - |
| dc.identifier.doi | 10.1155/2017/1378175 | - |
| dc.identifier.scopusid | 2-s2.0-85029788883 | - |
| dc.identifier.wosid | 000408348800001 | - |
| dc.identifier.bibliographicCitation | OXIDATIVE MEDICINE AND CELLULAR LONGEVITY, v.2017, pp 1 - 14 | - |
| dc.citation.title | OXIDATIVE MEDICINE AND CELLULAR LONGEVITY | - |
| dc.citation.volume | 2017 | - |
| dc.citation.startPage | 1 | - |
| dc.citation.endPage | 14 | - |
| dc.type.docType | Review | - |
| dc.description.isOpenAccess | Y | - |
| dc.description.journalRegisteredClass | scie | - |
| dc.description.journalRegisteredClass | scopus | - |
| dc.relation.journalResearchArea | Cell Biology | - |
| dc.relation.journalWebOfScienceCategory | Cell Biology | - |
| dc.subject.keywordPlus | DAUNORUBICIN-INDUCED NEPHROTOXICITY | - |
| dc.subject.keywordPlus | ERYTHROID 2-RELATED FACTOR-2 | - |
| dc.subject.keywordPlus | ACUTE LUNG INJURY | - |
| dc.subject.keywordPlus | RECEPTOR-GAMMA | - |
| dc.subject.keywordPlus | HEME OXYGENASE-1 | - |
| dc.subject.keywordPlus | BARDOXOLONE METHYL | - |
| dc.subject.keywordPlus | 15-DEOXY-DELTA(12,14)-PROSTAGLANDIN J(2) | - |
| dc.subject.keywordPlus | ANTIOXIDANT PROPERTIES | - |
| dc.subject.keywordPlus | SIGNALING MOLECULES | - |
| dc.subject.keywordPlus | PROTEIN OXIDATION | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
30, Pildong-ro 1-gil, Jung-gu, Seoul, 04620, Republic of Korea+82-2-2260-3114
Copyright(c) 2023 DONGGUK UNIVERSITY. ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.
